Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Researchers created a stable rabbit cell line for hair research that doesn't age quickly or become cancerous.

Dutasteride may help treat frontal fibrosing alopecia.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Vitamin D analogues can significantly help hair regrowth in Alopecia Areata patients.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A 31-year-old man has a chronic skin condition with red plaques, hair loss, and swollen lymph nodes.

Pre-natal, internal, and external factors may contribute to the development of Autism Spectrum Disorder (ASD).

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Diffuse alopecia areata causes widespread hair thinning due to an autoimmune response.

Vitamin D receptor mutations can cause alopecia by affecting hair growth genes.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Retinoic acid helps activate hair growth in people with common hair loss by working on a specific cell growth pathway.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.